Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significance

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Minarik, Jiri ^a   Pika, Tomas ^a   Bacovsky, Jaroslav ^a   Petrova, Pavla ^a   Langova, Katerina ^a   Scudla, Vlastimil ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; SCATTER FACTOR; SYNDECAN 1; BIOLOGICAL MARKER; SDC1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER REGRESSION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; BLOOD; COMORBIDITY; CZECH REPUBLIC; METHODOLOGY; MIDDLE AGED; PARAPROTEINEMIA; PREVALENCE; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMORBIDITY; CZECH REPUBLIC; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOPONTIN; PARAPROTEINEMIAS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYNDECAN-1; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84861076380     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/356128     Document Type: Article

References (28)

1. Scudla V., Petrova P., Minarik J., Pika T., Bacovsky J., Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma Neoplasma 2011 58 6 499 506
2. Alexandrakis M. G., Passam F. H., Sfiridaki A., Kandidaki E., Roussou P., Kyriakou D. S., Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity American Journal of Hematology 2003 72 4 229 233 (Pubitemid 36383972)
3. Andersen N. F., Standal T., Nielsen J. L., Heickendorff L., Borset M., Srensen F. B., Abildgaard N., Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival British Journal of Haematology 2005 128 2 210 217
4. Saeki Y., Mima T., Ishii T., Ogata A., Kobayashi H., Ohshima S., Ishida T., Tabunoki Y., Kitayama H., Mizuki M., Katada Y., Asaoku H., Kitano M., Nishimoto N., Yoshizaki K., Maeda M., Kon S., Kinoshita N., Uede T., Kawase I., Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications British Journal of Haematology 2003 123 2 263 270 (Pubitemid 37305060)
5. Seidel C., Lenhoff S., Brabrand S., Anderson G., Standal T., Lanng-Nielsen J., Turesson I., Brset M., Waage A., Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy British Journal of Haematology 2002 119 3 672 676 (Pubitemid 35366207)
6. Vacca A., Ribatti D., Roccaro A. M., Frigeri A., Dammacco F., Bone marrow angiogenesis in patients with active multiple myeloma Seminars in Oncology 2001 28 6 543 550 (Pubitemid 33134413)
7. Rajkumar S. V., Leong T., Roche P. C., Fonseca R., Dispenzieri A., Lacy M. Q., Lust J. A., Witzig T. E., Kyle R. A., Gertz M. A., Greipp P. R., Prognostic value of bone marrow angiogenesis in multiple myeloma Clinical Cancer Research 2000 6 8 3111 3116 (Pubitemid 30637735)
8. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., Dammacco F., Bone marrow angiogenesis and progression in multiple myeloma British Journal of Haematology 1994 87 3 503 508 (Pubitemid 24230014)
9. Molina J. R., Rajkumar S. V., Bone marrow angiogenesis in multiple myeloma: closing in on the loop Haematologica 2003 88 2 122 124 (Pubitemid 37101487)
10. Sezer O., Niemller K., Eucker J., Jakob C., Kaufmann O., Zavrski I., Dietel M., Possinger K., Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma Annals of Hematology 2000 79 10 574 577
11. Du W., Hattori Y., Yamada T., Matsumoto K., Nakamura T., Sagawa M., Otsuki T., Niikura T., Nukiwa T., Ikeda Y., NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor Blood 2007 109 7 3042 3049 (Pubitemid 46482105)
12. Holt R. U., Fagerli U. M., Baykov V., R T. B., Hov H., Waage A., Sundan A., Brset M., Hepatocyte growth factor promotes migration of human myeloma cells Haematologica 2008 93 4 619 622 (Pubitemid 351536394)
13. Sato T., Hakeda Y., Yamaguchi Y., Mano H., Tezuka K. I., Matsumoto K., Nakamura T., Mori Y., Yoshizawa K., Sumitani K., Kodama H., Kumegawa M., Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6) Journal of Cellular Physiology 1995 164 1 197 204
14. Fuller K., Owens J., Chambers T. J., The effect of hepatocyte growth factor on the behaviour of osteoclasts Biochemical and Biophysical Research Communications 1995 212 2 334 340
15. Standal T., Abildgaard N., Fagerli U. M., Stordal B., Hjertner., Borset M., Sundan A., HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma Blood 2007 109 7 3024 3030 (Pubitemid 46482103)
16. Pour L., Kovov L., Buchler T., Adam Z., Penka M., Vorlek J., Hjek R., Evaluation of HGF and endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae 2009 82 2 123 126
17. Seidel C., Brset M., Turesson I., Abildgaard N., Sundan A., Waage A., Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma Blood 1998 91 3 806 812 (Pubitemid 28078282)
18. Sezer O., Jakob C., Eucker J., Niemller K., Gatz F., Wernecke K. D., Possinger K., Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma European Journal of Haematology 2001 66 2 83 88 (Pubitemid 32154100)
19. Pour L., Svachova H., Adam Z., Mikulkova Z., Buresova L., Kovarova L., Buchler T., Penka M., Vorlicek J., Hajek R., Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma Neoplasma 2010 57 1 29 34
20. vchov H., Pour L., Alma M., Nmec P., Krlov D., Kovov L., Penka M., Vorlek J., Hjek R., Concentration of hepatocyte growth factor and thrombospondin predict treatment response in patients with multiple myeloma Transfuze a Hematologie Dnes 2010 16 1 30 34
21. Colla S., Morandi F., Lazzaretti M., Rizzato R., Lunghi P., Bonomini S., Mancini C., Pedrazzoni M., Crugnola M., Rizzoli V., Giuliani N., Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients Leukemia 2005 19 12 2166 2176 (Pubitemid 41741611)
22. Standal T., Hjorth-Hansen H., Rasmussen T., Dahl I. M. S., Lenhoff S., Brenne A. T., Seidel C., Baykov V., Waage A., Brset M., Sundan A., Hjertner., Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma Haematologica 2004 89 2 174 182 (Pubitemid 38796491)
23. Robbiani D. F., Colon K., Ely S., Ely S., Chesi M., Bergsagel P. L., Osteopontin dysregulation and lytic bone lesions in multiple myeloma Hematological Oncology 2007 25 1 16 20 (Pubitemid 46474310)
24. Sfiridaki A., Miyakis S., Pappa C., Tsirakis G., Alegakis A., Kotsis V., Stathopoulos E., Alexandrakis M., Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma Journal of Hematology and Oncology 2011 4, article 22
25. Yang Y., Yaccoby S., Liu W., Kevin Langford J., Pumphrey C. Y., Theus A., Epstein J., Sanderson R. D., Soluble syndecan-1 promotes growth of myeloma tumors in vivo Blood 2002 100 2 610 617 (Pubitemid 34761126)
26. Purushothaman A., Uyama T., Kobayashi F., Yamada S., Sugahara K., Rapraeger A. C., Sanderson R. D., Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis Blood 2010 115 12 2449 2457
27. Seidel C., Sundan A., Hjorth M., Turesson I., Dahl I. M. S., Abildgaard N., Waage A., Brset M., Serum syndecan-1: a new independent prognostic marker in multiple myeloma Blood 2000 95 2 388 392 (Pubitemid 30041645)
28. udla V., Budkov M., Petrov P., Minak J., Pika T., Baovsk J., Adamov D., Langov K., Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma Klinicka Onkologie 2010 23 3 171 181